SEC Form 4 · accession 0001209191-19-018962
Translate Bio, Inc. · TBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ronald C Renaud Jr.
Officer — Chief Executive Officer · Director · Other
Period of report
Mar 8, 2019
Accepted (ET)
Mar 12, 2019 · 6:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001693415
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $7.95 | Mar 8, 2019 | A | 500,000 | A | — | Mar 7, 2029 | Common Stock | 500,000 | 500,000 | D |
Explanation of responses
- F1This option will vest as to 25% of the shares on March 8, 2020, and in thirty-six equal monthly installments thereafter as to the remaining shares through March 8, 2023.